This New Single Dose Flu Drug Could Be Coming to the U.S. Before the Next Flu SeasonThe FDA granted a priority review to Genentech's novel, one-and-done flu drug.
Pharma Bets on Blockchain to Track MedsNo more counterfeits?
The FDA Has Approved a Crazy Number of New and Groundbreaking Drugs This Year20 new drugs in 2017 to date. There were just 22 in all of 2016.
How Medical Researchers Are Breaking the Blood-Brain BarrierBetter drugs for Alzheimer's and other brain disorders could follow.
How Mylan Is Taking On One of the World's Top Breast Cancer DrugsIts biosimilar of Roche's Herceptin showed promising results.
A Guide to ASCO, Biopharma's Biggest Cancer ConferenceCancer drug innovation is the name of the game.
Intel Invests in Lightbend and Its Scala LanguageLightbend backs Scala, a fan favorite programming language for big data applications.
Skip to Content
